UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Factors associated with quality of life in Italian children and adolescents with IBD

Scientific reports, 2021-09, Vol.11 (1), p.18076-18076, Article 18076

2021

Volltextzugriff (PDF)

Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry

Journal of pediatric gastroenterology and nutrition, 2018-06, Vol.66 (6), p.920-925

2018

Volltextzugriff (PDF)

Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?

Paediatric drugs, 2020-10, Vol.22 (5), p.463-472

2020

Volltextzugriff (PDF)

Safety of Biological Therapy in Children With Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2021-05, Vol.72 (5), p.736-741

2021

Volltextzugriff (PDF)

Natural History of Anemia and Efficacy and Safety of Oral Iron Therapy in Children Newly Diagnosed With Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2023-06, Vol.76 (6), p.771-775

2023

Volltextzugriff (PDF)

A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn’s Disease Improves Outcomes at 2 Years

Inflammatory bowel diseases, 2024-08, Vol.30 (8), p.1303-1308

2024

Volltextzugriff (PDF)

Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease

Inflammatory bowel diseases, 2023-07, Vol.29 (7), p.1057-1064

2023

Volltextzugriff (PDF)

Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn Disease?

Journal of pediatric gastroenterology and nutrition, 2021-08, Vol.73 (2), p.242-246

2021

Volltextzugriff (PDF)

Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN

Inflammatory bowel diseases, 2023-09

2023

Volltextzugriff (PDF)

Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab

Journal of pediatric gastroenterology and nutrition, 2019-06, Vol.68 (6), p.841-846

2019

Volltextzugriff (PDF)

Mucosal healing in Crohn's disease: new insights

Expert review of gastroenterology & hepatology, 2020-05, Vol.14 (5), p.335-345

2020

Volltextzugriff (PDF)

Quality of life in long term survivors of pediatric intestinal transplantation compared with liver transplantation and home parenteral nutrition: A prospective single‐center pilot study

Pediatric transplantation, 2021-05, Vol.25 (3), p.e13982-n/a

2021

Volltextzugriff (PDF)

Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study

Journal of pediatric gastroenterology and nutrition, 2022-01, Vol.74 (1), p.79-84

2022

Volltextzugriff (PDF)

Aortic Intima‐Media Thickness as an Early Marker of Atherosclerosis in Children With Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2015-07, Vol.61 (1), p.41-46

2015

Volltextzugriff (PDF)

Histologic findings at diagnosis as predictive markers of clinical outcome in pediatric ulcerative colitis

Digestive and liver disease, 2024-01, Vol.56 (1), p.106-111

2024

Volltextzugriff (PDF)

Diagnostic accuracy of multimodal noninvasive follow‐up for pediatric ulcerative colitis: A single‐center prospective study

Journal of pediatric gastroenterology and nutrition, 2024-02, Vol.78 (2), p.280-288

2024

Volltextzugriff (PDF)

Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy

Digestive and liver disease, 2015-06, Vol.47 (6), p.455-459

2015

Volltextzugriff (PDF)

Increased Use of Anti‐Tumor Necrosis Factor Following the Implementation of the ECCO–ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease

Journal of pediatric gastroenterology and nutrition, 2022-01, Vol.74 (1), p.79-84

2022

Volltextzugriff (PDF)

Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn's Disease?

Journal of pediatric gastroenterology and nutrition, 2021-04

2021

Volltextzugriff (PDF)

Su2021 - Mucosal Healing and Histological Remission in Pediatric Ulcerative Colitis: Does the Target Change the Outcomes?

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-668-S-668

2018

Volltextzugriff (PDF)

Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease

Digestive and liver disease, 2013-06, Vol.45 (6), p.464-468

2013

Volltextzugriff (PDF)

Su2019 - A Treat-To Target Strategy Guided by Pan-Enteric Evaluation in Children with Crohn's Disease Improves Outcomes at 2 Years

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-668-S-668

2018

Volltextzugriff (PDF)

Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group

Digestive and liver disease, 2024-01, Vol.56 (1), p.70-76

2024

Volltextzugriff (PDF)

Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group

Digestive and liver disease, 2021-03, Vol.53 (3), p.283-288

2021

Volltextzugriff (PDF)

Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group

Digestive and liver disease, 2021-02, Vol.53 (2), p.183-189

2021

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(67)

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Factors associated with quality of life in Italian children and adolescents with IBD

Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry

Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?

Safety of Biological Therapy in Children With Inflammatory Bowel Disease

Natural History of Anemia and Efficacy and Safety of Oral Iron Therapy in Children Newly Diagnosed With Inflammatory Bowel Disease

A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn’s Disease Improves Outcomes at 2 Years

Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease

Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn Disease?

Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN

Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab

Mucosal healing in Crohn's disease: new insights

Quality of life in long term survivors of pediatric intestinal transplantation compared with liver transplantation and home parenteral nutrition: A prospective single‐center pilot study

Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study

Aortic Intima‐Media Thickness as an Early Marker of Atherosclerosis in Children With Inflammatory Bowel Disease

Histologic findings at diagnosis as predictive markers of clinical outcome in pediatric ulcerative colitis

Diagnostic accuracy of multimodal noninvasive follow‐up for pediatric ulcerative colitis: A single‐center prospective study

Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy

Increased Use of Anti‐Tumor Necrosis Factor Following the Implementation of the ECCO–ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease

Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn's Disease?

Su2021 - Mucosal Healing and Histological Remission in Pediatric Ulcerative Colitis: Does the Target Change the Outcomes?

Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease

Su2019 - A Treat-To Target Strategy Guided by Pan-Enteric Evaluation in Children with Crohn's Disease Improves Outcomes at 2 Years

Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group

Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group

Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group

Aktive Filter

Suchergebnisse filtern